JPRN-UMIN000001494已完成3 期
Phase III Study of adjuvant chemotherapy for the patients resected pathological stage I(T1>2cm) Non Small Cell Lung Cancer (JCOG0707) - Phase III Study of adjuvant chemotherapy for the patients resected pathological stage I(T1>2cm) Non Small Cell Lung Cancer (JCOG0707)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 960 人开始时间: 2008年11月10日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 960
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active another neoplasm 2) severe postoperative complications 3) severe complications 4) history of severe hypersensitivity(>=Grade3) 5) Concomitant therapy with flucytocine, phenytoin or Warfarin Potassium 6) pregnant or lactating women 7) serious psychiatric illness 8) HIV positive
研究者
相似试验
已完成
不适用
Phase I Study of adjuvant chemotherapy for the patients resected pathological stage IA(T1>2cm) Non Small Cell Lung Cancer (SLCG0701)JPRN-UMIN000006967Setouchi Lung Cancer Group80
尚未招募
2 期
PhaseIII trial of neoadjuvant chemotherapy using CAPEOX with optional local treatment for locally advanced rectal cancerocally advanced rectal cancerJPRN-UMIN000032254Yokohama City University440
进行中（未招募）
不适用
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low-risk for recurrence: NVALT-8A - NVALT-8AThis is a randomized multicenter phase III study. Patient with a low SUV of the primary tumor prior to surgery will be randomised to four cycles of cisplatin-based chemotherapy or observation in a non-inferiority design.EUCTR2007-002644-21-NLMCG
已完成
3 期
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small-cell lung cancer patients with high-risk for recurrence: NVALT- 8B.10038666lung cancerNon-small cell lung cancerNL-OMON35584niversitair Medisch Centrum Groningen600
尚未招募
3 期
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low risk for recurrence: NVALT-8AlungcancerNon-smal cell lung cancer10038666NL-OMON34015niversitair Medisch Centrum Groningen864